Abstract: Compositions including a first soft tissue-derived matrix and a second soft tissue-derived matrix are provided, as well as methods of making such compositions. In some embodiments, the composition comprises dilapidated, decellularized adipose tissue-derived matrix and dilapidated, decellularized fascial tissue-derived matrix, which may be combined in various proportions. Such adipose-fascia matrix compositions provide improved volume retention when implanted into a patient. The composition may further include exogenous cells or other substances, and/or a carrier. The composition is suitable for use inplastic surgery procedures, including reconstructive or cosmetic surgery procedures, as well as procedures for wound treatment and tissue regeneration.

Abstract: A hydrogel comprising: water; an alginate; a glucono-delta-lactone (GDL); and microparticles comprising an inorganic calcium compound and recombinant gelatin. The hydrogels may be used for bone repair and/or regeneration.

Abstract: In some embodiments, a method of fabricating a skin wound patch includes preparing a biopolymeric solution comprising chitosan, collagen, chondroitin sulfate, elastin, hyaluronic acid, follistatin-like 1 (FSTL-1), iron oxide nanoparticles, and AC2-26 peptide, filtering the biopolymeric solutions through a filter membrane, extruding the biopolymeric solution through an extrusion device to form a nanofibrous composite, collecting the extruded nanofibrous composite on a sterilized plate, and drying the extruded nanofibrous composite into a solid patch. In some embodiments, a skin wound patch includes homogeneously distributed biomolecules, skin materials, pro-inflammatory, and antibacterial agents. In further embodiments, a method of treating a chronic skin wound in a subject in need thereof can include applying any of the patches described herein.

Abstract: In one aspect, the disclosure relates to compositions, methods, and devices pertaining to polymeric nanoparticle compositions (pNP), pNP compositions comprising a therapeutic agent, devices comprising a drug-coated balloon comprising a disclosed pNP comprising a therapeutic agent, and methods for treating peripheral artery disease using the disclosed compositions and devices. In further aspects, the pNP comprises a poly (lactic-co-glycolic) acid possessing a positive charge for firm attachment to the balloon matrix, followed by adhesion to the negatively charged bilayer of the vascular wall. In still further aspects, the therapeutic agent comprises a resveratrol or derivative thereof, a quercetin or derivative thereof, or combinations thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Abstract: Embodiments are directed to radiopaque implantable structures (e.g., stents) formed of cobalt-based alloys that comprise cobalt, chromium, tungsten, and nickel, and methods for their manufacture. Tungsten is present above its solubility limit (about 15%) at ambient temperature, but is still only present as a super-saturated, primarily single-phase material exhibiting an FCC microcrystalline structure.

Abstract: An apparatus includes a first layer, wherein the first layer comprises a scaffold structure forming an inner lumen along a length of the scaffold structure, and wherein the first layer comprises a bioresorbable material; a second layer on the first layer, wherein the second layer comprises a bioresorbable material configured to expand, wherein the second layer is positioned on the first layer such that ends of the first layer extend beyond ends of the second layer; and an expandable balloon located within a distal end of the inner lumen of the first layer.

Abstract: The present invention relates to biomaterials coated with an active agent eluting coating, wherein implantation of the coated biomaterial results in reduced implant-related complications and/or improved integration of the biomaterial into the host tissue and further relates to kits containing the coated biomaterial. The present invention also relates to methods and kits for coating the biomaterial. It is based, at least in part, on the discovery that biomaterial coated with a cytokine eluting coating resulted in the shift of early stage macrophage polarization that were associated with positive long-term effects such as minimized capsule formation and improved tissue quality and composition as compared to uncoated biomaterials.

Abstract: A manifold for connection to a waste collection vacuum device. The manifold includes suction port tubes and a vacuum port that define interconnected fluid communication pathways such that no walls define proximal and distal ends of the manifold. Tabs are coupled to at least one of the interconnected fluid communication pathways. The tabs interface with keyed surfaces of the waste collection vacuum device so as to facilitate positive location and mechanical fixation with the waste collection vacuum device. The manifold may include a body, and a flow director may be disposed within the body. A filter element may also be disposed within the body and include a distal section having a cross-sectional area less than a cross-sectional area of a proximal section. Each of the distal and proximal sections may define apertures configured to trap liquid, semi-solid, or solid waste within the fluid path.

Abstract: The invention relates to a device for rinsing a body cavity, wherein a pressure sensor for determining the actual pressure in the body cavity is provided, said pressure sensor being arranged in the drainage line (8).

Abstract: The present invention comprises a fluid source connected to an irrigation feed line, an aspiration line providing at least a partial vacuum at a surgical site, at least one pressure sensor in communication with the aspiration line, and at least one valve in communication with the irrigation feed line, wherein the at least one valve restricts fluid flow in the irrigation feed line in accordance with at least one measurement of aspiration pressure differential and at least one predetermined system attribute, and wherein the aspiration pressure differential may equal a first measurement of aspiration pressure minus a second measurement of aspiration pressure over a predetermined time.

Abstract: Embodiments of negative pressure wound therapy devices, systems and methods are disclosed. In some embodiments, a negative pressure wound therapy device includes a negative pressure source configured to provide negative pressure to a wound via a fluid flow path, a power source configured to power the negative pressure source, and a charging circuit configured to monitor a temperature of the power source and charge the power source. The charging circuit can be further configured to in response to a determination that the temperature of the power source is below a temperature threshold, provide a first charging power to the power source. The charging circuit can be further configured to in response to a determination that the temperature of the power source has reached or is above the temperature threshold, lower the first charging power to a second charging power.

Abstract: A negative pressure wound therapy device can include a negative pressure source and a controller configured to activate the negative pressure source for a first duration of time to attempt to reduce pressure under the wound dressing to approximately a negative pressure set point, subsequent to expiration of the first duration of time, deactivate the negative pressure source after pressure under the wound dressing is reduced to approximately the negative pressure set point, activate the negative pressure source for a second duration of time to attempt to reduce pressure in the fluid flow path, the second duration of time subsequent to the first duration of time, determine a pressure change in a fluid flow path over the second duration of time, and, in response to determining that the pressure change in the fluid flow path over the second duration of time indicates reduction in pressure, provide indication of a blockage.

Abstract: A NPWT wound care device for treatment of large wounds with negative pressure that includes an open-cell porous foam layer, a skin-safe fluid-permeable contact layer on a bottom surface of the foam layer that is configured to be placed in direct contact with an open wound of a patient, and a top air-sealed layer on an upper surface of foam opposite of the fluid-permeable contact layer. The wound care device defines an outer perimeter along an edge of the foam layer that includes a skin-safe adhesive and is configured to form an air-tight seal in conjunction with the air-sealed layer against a patient's skin.

Abstract: An apparatus for extracorporeal treatment of fluid and a process of setting up a medical apparatus for the delivery or collection of fluids are disclosed. According to the apparatus and the process, a control unit (10) is configured calculate set values of two or more of the fluid flow rates based on a fluid flow rate set by the operator and on a prescribed dose value (Dset).

Abstract: A fluid conduit includes a first portion having a first porosity, a second portion disposed immediately adjacent to the first portion, the second portion having a second porosity that is greater than the first porosity, and a third portion of the fluid conduit disposed immediately adjacent to the second portion, the third portion having a third porosity that is less than the second porosity. Each of the first portion, the second portion, and the third portion may be integrally formed as a single, continuous piece defining the fluid conduit.

Abstract: The present disclosure relates to a holder for releasably coupling at least one external medical module, for example a blood filter, to a medical treatment apparatus, wherein the holder comprises at least a first reception unit and a second reception unit.

Abstract: Techniques for monitoring fluid volumes during peritoneal analysis include: computing lower abdominal fluid volumes, continuously during a dwell time of a peritoneal dialysis treatment, based at least on bioimpedance data from electrodes positioned on a patient's upper thighs; and computing intraperitoneal volumes, continuously during the dwell time of the peritoneal dialysis treatment, based at least on bioimpedance data from the electrodes positioned on the patient's upper thighs and electrodes positioned on the patient's torso.

Abstract: The present disclosure relates to non-hemolytic adsorbent compositions useful for isolating, enumerating, accounting, and removing the disease-causing toxic constituents in the blood. The said compositions are useful in identifying the disease, disease status, and validating the efficacy of the therapeutic treatment being administered for the treatment of the disease. Methods for isolating, enumerating, accounting, and removing disease-causing toxic constituents in the blood as well as monitoring the disease status and validating the efficacy of the therapeutic treatment being administered for the treatment of the disease are disclosed.

Abstract: This invention discloses methods for reducing physiologic molecules in abnormal levels and/or exogenous toxins in blood from blood by way of an extracorporeal circuit comprising a hollow-fiber filter module and polymer sorbent in combination.

Abstract: A medical device includes a case obtained by mating a liquid-phase-portion case and a gas-phase-portion case to each other, a membrane member as an elastic member with which a liquid-phase portion covered by the liquid-phase-portion case and a gas-phase portion covered by the gas-phase-portion case are separated from each other, fixing parts and at which the liquid-phase-portion case and the gas-phase-portion case that are mated to each other are fixed to each other, holding surfaces and between which a peripheral edge of the membrane member is held, and a sealing part that seals the entirety of the peripheral edge of the membrane member held between the holding surfaces and. The medical device has a releasing part that releases the pressure in an air gap produced between the sealing part and the fixing parts.

Abstract: The invention relates to a degassing devive (25) for degassing blood, comprising a blood chamber (1, 1a, 1b) with a blood inlet (2) and a blood outlet (3), via which blood can be guided/is guided through the blood chamber (1, 1a, 1b), at least one underpressure chamber (11) with an underpressure attachment (8) via which the at least one underpressure chamber (11) is provided with an underpressure, at least one semipermeable membrane (4, 4a), which is arranged between the at least one underpressure chamber (11) and the blood chamber (1), wherein the blood chamber (1) comprises a first and a second sub-chamber (1a, 1b) which are arranged next to each other in a direction perpendicular to the direction of gravity, and a bridging region (9) which connects the two subchambers (1a, 1b) at their upper ends, wherein the blood inlet (2) is arranged in the lower region of the first subchamber (1a), and the blood outlet (3) is arranged in the lower region of the second subchamber (1b).

Abstract: A method of circulating a flow of blood within a circulatory system of a body includes applying an extrathoracic pressure to the body with a fluid. An intrathoracic pressure is applied to the body with the fluid. The application of the extrathoracic pressure relative to the application of the intrathoracic pressure is varied, so as to circulate a flow of blood within the circulatory system of the body.

Abstract: The present disclosure relates to systems and methods for the separation of blood into blood products and, more particularly, to systems and methods that permit automated recovery of white blood cells after producing a leukocyte-reduced blood product.

Abstract: Multilayer tubing balances the property of improved kink resistance, reduces post occlusion surge, and reduces pump pulsations after surge. A multilayer construction is provided for tubing for phacoemulsification systems. Multilayer tubing includes multiple layers having an inner layer and an outer layer, wherein the material of the inner layer is harder or stiffer than the material of the outer layer.

Abstract: This nest comprises a plurality of breakable connecting bridges, a plurality of flanges arranged in a predetermined pattern and configured to form the flanges of the medical containers, the flanges being connected to the breakable connecting bridges, and a supporting structure attached to the breakable connecting bridges so as to support the flanges. The flanges are integrally formed with the breakable connecting bridges and the supporting structure.

Abstract: Multi-medicament infusion systems prevent cross-channeling of medicaments. A system may include one or more of an infusion pump, medicament reservoirs, a multi-channel fluid conduit, and an infusion set. Medicament reservoirs and/or collars may be sized and shaped differently such that the medicament reservoirs can only be inserted into the system under selected configurations.

Abstract: Disclosed herein is an insertion device for installation of a medical device comprising a transcutaneous element. The insertion device includes a device holder for holding the medical device. The insertion device also includes an installation surface configured to contact the medical device so as to deploy the transcutaneous element of the medical device. The insertion device also includes an elastic installation element configured to apply a force to the installation surface so as to bring the installation surface into contact with the medical device. The insertion device also includes a tensioner configured to adjust the force applied by the elastic installation element to the installation surface.

Abstract: A gas extraction device for a fluid delivery apparatus includes a first layer and a vent membrane coupled to the first layer. The vent membrane enables a gas to pass through the vent membrane and prevents a fluid from passing through the vent membrane. The gas extraction device also includes a second layer coupled to the vent membrane opposite the first layer. The second layer has a first channel formed therethrough. In addition, the gas extraction device includes an impermeable membrane coupled to the second layer opposite the vent membrane. The first channel is configured to receive a fluid having a gas dispersed therein. The fluid is pressurized to move the fluid through the first channel against the vent membrane and to move the gas through the vent membrane.

Abstract: A fluid injection system that includes an injector head having a syringe for delivering a fluid to a patient; a mounting structure pivotally connected to the injector head and configured to support the injector head above a surface; and a control system operationally coupled to the injector head for controlling an injection procedure is disclosed. The fluid injection system is provided with various sensors to control various aspects of the fluid injection system, such as the establishment of a reference plane, the determination of a tilt angle of the injector head, and the determination of a temperature of an actuation system of the injector head.

Abstract: A sensor for detecting infiltration at a catheter infusion site may include a first elongate sensor member couplable to a first location proximate the catheter infusion site, and a second elongate sensor member couplable to a second location proximate the catheter infusion site. The first elongate sensor member may include a first marking and the second elongate sensor member may include a second marking. The first elongate sensor member may slidably couple with and translate relative to the second elongate sensor. The first and second markings may indicate a range of relative positions between the first and second elongate sensor members as the first and second elongate sensor members translate relative to each other. At least one relative position within a range of relative positions between the first and second elongate sensor members may be indicative of infiltration at the catheter infusion site.

Abstract: A glucose control system employs adaptation of a glucose target (set-point) control variable in controlling delivery of insulin to a subject to maintain euglycemia. The glucose target adapts based on trends in actual glucose level (e.g., measured blood glucose in the subject), and/or computed doses of a counter-regulatory agent such as glucagon. An adaptation region with upper and lower bounds for the glucose target may be imposed. Generally the disclosed techniques can provide for robust and safe glucose level control. Adaptation may be based on computed doses of a counter-regulatory agent whether or not such agent is actually delivered to the subject, and may be used for example to adjust operation in a bihormonal system during periods in which the counter-regulatory agent is not available for delivery.

Abstract: The present disclosure relates to a administration assembly for a medicament delivery device, comprising: an elongated tubular delivery member cover (7), a cartridge holder (11) configured to be received by the delivery member cover (7) and configured to accommodate a medicament cartridge (31), the cartridge holder (11) having a radially flexible and radially inwards extending cartridge blocking protrusion (11b) configured to prevent the medicament cartridge (31) from moving proximally until being subjected to a proximally directed force larger than a threshold value, a needle assembly (13) comprising a double-edged needle having a proximally extending needle portion (13a) and a distally extending needle portion (13b), wherein the needle assembly (13) is configured to be assembled with the cartridge holder (11) so that the distally extending needle portion (13b) extends into the cartridge holder (11), and an administration mechanism including a plunger rod (27) configured to be proximally biased, wherein the

Abstract: An autoinjection device (10) for expelling a dose of drug from a held drug container (100) is described.

Abstract: A medicament container holder is presented having a body designed to accommodate at least a part of a medicament container and is arranged with a medicament delivery member surrounded by a needle shield; a holding element arranged at a proximal end of the body for holding a neck portion of the medicament container. The holding element being flexible in generally radial directions and support elements provided between the holding element and the body, where the support elements allow generally outwardly movement of the holding element from a first initial position during passing of the needle shield when the medicament container is placed in the medicament container holder, ensuring inwardly movement of the holding element after passing of the needle shield, returning the holding element towards the first initial position to a second position, and promoting generally inwardly action of the holding element to a third position during attachment of a needle shield remover to the needle shield.

Abstract: A kit for the direct use of a variety of medical ampoules of differing sizes, with a syringe, the kit having: a syringe body; a syringe plunger having a hollow interior volume; and a plurality of ampoule interface elements, each one being interchangeably received within the hollow interior volume and configured for deployment between an outer surface of the medical ampoule and a surface of the hollow interior volume so as to hold the medical ampoule therein, each of the plurality of ampoule interface elements having an outside diameter sized to fit an inside diameter of the hollow interior volume, wherein a first of the ampoule interface elements has an inside diameter for receiving a medical ampoule of a first size, and a second of the ampoule interface elements has an inside diameter different from the first inside diameter for receiving a medical ampoule of a second size.

Abstract: The present invention improves the feeling in use when a finger is hooked on a finger grip. This syringe is provided with a cylinder 22, a syringe needle 24, a finger grip 30, and a plunger rod 32. The finger grip 30 is provided with a cylindrical portion and a pair of finger hook portions. The finger hook portion has an inclined curved surface 70 and an end-side curved surface 72. The inclined curved surface 70 is disposed on a side, of a side surface of the finger hook portion, connected to the cylinder 22. In the inclined curved surface 70, the inclination of a base-side region with respect to the center axis of the cylindrical portion is gentler than the inclination of an end-side region with respect to the center axis of the cylindrical portion. The end-side curved surface 72 is disposed at the boundary between the end of the finger hook portion and the inclined curved surface 70. The end-side curved surface 72 extends along the boundary.

Abstract: A supplementary device configured to be attached to a drug delivery device, the supplementary device including: first means being adapted to mechanically couple the supplementary device to a dosage selector of the drug delivery device; second means being adapted to select a dosage to be delivered by the drug delivery device; third means being adapted to mechanically couple the second means to the first means such that a dosage selection made with the second means generates a torque being transferred via the third means to the first means; a sensor configured to output signals indicative of the generated torque; and electronics configured to receive the signals output from the sensor and to determine based on the signals the selected dosage.

Abstract: The present invention relates to a prefillable syringe with safety features that renders it auto-disable with user-controlled needle retraction after use. These features prevent re-use and greatly minimise the risk of needle stick injuries. The prefillable syringe has simple mechanisms that are devoid of any spring components and enables efficient administration of medicine without any possibility of leakage. The autodisable mechanism occurs via a locking arrangement between the needle holder and plunger, while needle retraction is facilitated via a locking arrangement between the plunger and plunger extension. Tamper prevention of the auto-disable mechanism occurs through a uniquely designed finger flange extension and/or barrel design modification. The unique design of the barrel tip allows for the needle cap to securely form a seal over the needle (if staked) to prevent any leakage prior to use.

Abstract: An apparatus includes a first member and a second member. The first member is configured to receive a portion of a syringe barrel and includes a first stop surface. The second member includes a second stop surface. Each stop surface is configured to engage the portion of a plunger to thereby arrest longitudinal movement of the plunger relative to the syringe barrel. The second member is operable to move relative to the first member from a first position to a second position. The second member remains coupled with the first member while in both the first position and the second position. The second stop surface engages the portion of the plunger when the second member is in the first position. The second stop surface does not prevent the portion of the plunger from reaching the first stop surface when the second member is in the second position.

Abstract: The present disclosure relates to a touch sensitive label for an injection device, the label comprising: —a flexible substrate (101) configured for attachment to a housing (10) of the injection device (1), —an electronic display (110) located on the substrate (101) and configured to visually display at least one indication (111), —a touch sensitive area (120) located on the substrate (101) and electrically connectable to the electronic display (110), —a processor (140) connected to the electronic display (110) and configured to modify the visual appearance of the at least one indication (111) in response to a user touching or depressing the touch sensitive area (120).

Abstract: A needle syringe has a plunger and a needle for filling and dispensing liquid from the cavity. The cavity has finger clip with movable locking pins. The plunger has at least one set of grooves corresponding to a specific dosage for the needle syringe, the specific dosage of the groove being demarked by a marking ledge that indicates a change to a deeper depth section of the groove. The locking pins are configured to rest in the at least one set of grooves, such that when the plunger is removed, the locking pins pass within a first shallow section of the groove, pass over the ledge, and continue to pass in the deeper depth section of the groove. When the plunger is depressed in a first partial dispensing movement, the locking pins pass in the deeper depth section of the groove until the plunger depression is temporarily locked when the locking pins reach the ledge, where the dose remaining in the cavity is the specific dosage.

Abstract: A drive mechanism for a medicament delivery device is presented having an activation rod provided with external activation rod threads having a first thread helix angle, an activation knob rotationally locked with the activation rod, wherein the activation knob is configured to be moved between a first axial position relative to the activation rod in which the activation knob is prevented from rotation and a second axial position in which the activation knob is allowed to rotate in a first direction, an axially slidable drum which is rotationally locked, a dose drum rotationally locked relative to the activation rod, wherein the dose drum is configured to rotate relative to the slidable drum, an indicator drum provided with external indicator drum threads having a second thread helix angle, wherein rotation of the activation knob in the first direction causes concurrent first rotation of the activation rod and the dose drum in accordance with the first thread helix angle.

Abstract: Described herein is a needle protective cover having a cylindrical barrel, a funnel, and a support mechanism. The cylindrical barrel has a proximal end and a distal end and is operable to receive a hypodermic needle or hypodermic needle sheath. The funnel is at the proximal end of the cylindrical barrel. The support mechanism surrounds the cylindrical barrel and funnel, such that the support mechanism is operable to prevent the needle protective cover from rolling on a surface and increases a distance from the funnel to the surface. The support mechanism may be a triangular body and/or one or more fins.

Abstract: A syringe device includes a barrel and a compressible portion is connected to one end of the barrel. A positioning board is located between the barrel and the compressible portion. The positioning board has a hole defined therethrough. A seat is formed to the underside of the positioning board and has a recess and multiple guide grooves which communicate with the recess. A hold part is connected to the distal end of the compressible portion and has a penetrating face. Two flanges respectively extend diametrically from the hold part. A needle is connected to the positioning board and communicates with the recess. The tip of the needle is located within the compressible portion and beneath the penetrating face. By axially compressing the compressible portion and the barrel, the needle penetrates through the penetrating face and extends beyond the hole to eject medicine to the patient.

Abstract: An air removal device for an intravenous fluid system includes a housing with an inlet for fluid communication with a fluid source, a fluid outlet for fluid communication with a blood vessel of a patient, and an air outlet. The air removal device further includes a disrupting element disposed within the housing in a flow path between the inlet and the fluid outlet, and an air chamber in fluid communication with the air outlet. The disrupting element includes a protrusion extending across the flow path. The flow path includes a first cross-sectional flow area at the inlet, and a second cross-sectional flow area at the protrusion. The second cross-sectional flow area is smaller than the first cross-sectional flow area.

Abstract: An apparatus having an outer wall that encompasses an interior chamber that holds a predetermined volume of fluid and gas where the gas rises to one end of the interior chamber and the fluid flows to the other end of the interior chamber. The apparatus also has an inlet port that allows for fluid to ingress into the interior chamber and an outlet port that allows for fluid to egress out of the interior chamber.

Abstract: The present disclosure provides a priming device, the priming device including: a housing having a proximal end and a distal end, the housing defining an axial direction extending substantially from the proximal end to the distal end; and a membrane disposed at the proximal end, wherein the housing defines a fluid communication channel extending substantially axially from an interior surface of the membrane towards the distal end and a filter disposed at the distal end of the housing, the filter being configured to allow a passage of air. In another aspect, there is provided a priming device having an adapter.

Abstract: A handheld digital nebulizer device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The handheld digital nebulizer device includes a housing having an exhalation valve, a reservoir, an ejector mechanism, and at least one differential pressure sensor. The handheld digital nebulizer device is automatically breath actuated by the user when the differential pressure sensor senses a predetermined pressure change within housing. The handheld digital nebulizer device is then actuated to generate a plume of droplets having an average ejected particle diameter within the respirable size range, e.g, less than about 5-6 ?m, so as to target the pulmonary system of the user.

Abstract: The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to a pumping chamber for such an inhalation device.

Abstract: There is provided a connector configured to be retrofitted to an electronic aerosol provision system including a first connecting interface connectable to a vaporizer for vaporizing liquid for inhalation by a user; a second connecting interface connectable to a power supply for supplying power to the vaporizer; a sensor for sensing a parameter indicative of a change in the electronic aerosol provision system; and a control unit connected to the sensor and configured to output a signal based on the information from the sensor, wherein the connector, when connected to a vaporizer and to a power supply, forms an electronic aerosol provision system.